Stockreport

Lifecore Biomedical: The Turnaround Is Just Getting Started [Seeking Alpha]

Lifecore Biomedical, Inc.  (LFCR) 
PDF LFCR's new capacity is underutilized but already contracted, with management guiding revenues to rise from $128M to $178–205M and EBITDA margins to expand from 15% to o [Read more]